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Abstract

The formation of well-ordered nanostructures through self-assembly of diverse organic and
inorganic building blocks has drawn much attention owing to their potential applications in biology
and chemistry. Among all organic building blocks, peptides are one of the most promising
platforms due to their biocompatibility, chemical diversity, and resemblance with proteins.
Inspired from the protein assembly in biological systems, various self-assembled peptide structures
have been constructed using several amino acids and sequences. This review focuses on this
emerging area, the recent advances in peptide self-assembly, and formation of different
nanostructures, such as tubular, fibers, vesicles, spherical, and rod coil structures. While different
peptide nanostructures are discovered, potential applications will be explored in drug delivery,
tissue engineering, wound healing, and surfactants.
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1. Introduction
Nanometer-sized structures have attracted major attention owing to their potential for
diverse applications ranging from nanotechnology to biotechnology. In biological systems,
proteins, DNA, cellular organelles, and microorganisms are submicron sized objects. Thus, they
can be considered as ‘biological nanostructures’ when compared to synthetic nanostructures.
Self-assembly is a spontaneous process of organization of chaotic molecular units into
ordered structures as a result of intramolecular/intermolecular interactions.1 The process of
assembly is controlled by the balance of attractive/repulsive forces within and between molecules.
The generation of many biological nanostructures occurs through the self-assembly process, such
as DNA double helix formation through hydrogen bonding interactions between nucleotide bases,
protein’s tertiary or quaternary structure through folding of a polypeptide chain, and the formation
of cell membranes upon self-assembly of phospholipids. The most straightforward and extensively
known self-assembled structure in a biological system is the lipid membrane structure. The cell
membrane consists of lipid bilayers that are arranged in such a way that their hydrocarbon tails
face one another to make a hydrophobic bilayer while their hydrophilic head groups are exposed
to aqueous solutions on each side of the membrane.
The self-assembly process is mediated through noncovalent interactions including van der
Waals, electrostatic, hydrogen bonding, and stacking interactions. The fabrication of new materials
using natural building blocks, such as phospholipids, oligosaccharides, oligonucleotides, proteins,
and peptides, has become a subject of major interest.2 Among them, peptides have drawn
significant attention due to their simple structure, relative chemical and physical stability, diversity
in sequences and shapes, and feasibility to synthesize in large amounts. In addition, peptides have
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become known as immensely useful building blocks for creating self-assembled nanostructures in
medical applications due to their intrinsic biocompatibility and biodegradability.
Proteins and peptides are made up of 20 natural L-amino acids. All of the natural amino
acids are chiral in nature except glycine and contain carboxylic acid and amino groups. The only
difference in their structure is in the side chain groups attached to the chiral carbon. Amino acids
as building blocks of peptides have various physicochemical properties, because of variety in
charge, hydrophobicity, size, and polarity in side chains. The number, type, and sequence of amino
acids can be manipulated to design self-assembled peptides. Depending upon the amino acid
sequence, the peptide can form different structures. Many human medical disorders are associated
with polypeptide self-assembly into amyloid fibrils.3
The versatility of the peptides, in conjunction with their ability to form specific secondary
structures, provides a unique platform for the design of nanomaterials with controllable structural
features. A number of peptide-based building blocks, such as cyclic peptides, amphiphilic
peptides, copolypeptides, surfactant-like oligopeptides, dendritic peptides, and aromatic
dipeptides, have been designed and developed for generating supramolecular structures and the
exploration of their possible applications in biology and nanotechnology. Key advantages of selfassembled peptides relative to conventional structures include biocompatibility, biodegradability,
and versatility.
Self-assembled peptide nanostructures have demonstrated considerable potential as
biomaterials4 and use for carrier-mediated drug delivery, tissue engineering, antimicrobial agents,
imaging tools, energy storage, biomineralization, and membrane protein stabilization.5 Thus, the
self-assembly properties of peptides have been exploited for generating bio-inspired
nanostructures, including nanotubes, nanofibers, nanospheres, nanobelts, and hydrogels.6
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Herein, we review representative examples and highlights of peptide nanostructures, such
as tubular, fibers, ribbons, vesicles, spherical structures, and rod coil structures. A comprehensive
review of all self-assembled peptide nanostructures is beyond the scope of this manuscript. We
apologize that many excellent works were not included here. Table 1 summarizes the sequences
of the peptides and the corresponding formed nanostructures discussed in this review.

2.

Peptide Nanostructures

2.1.

Tubular Nanostructures
Nanotubes are nanometer size tube-like structures. They are elongated nanostructures

which have definite inner hole. Nanotubes are particularly attractive because of their potential
applications in biology, chemistry, and physics, such as chemotherapy, drug delivery, catalysis,
molecular separation, optics, and electronics.7 Over the past few decades, researchers have made
significant progress in covalently bonded nanostructures. Currently, noncovalent nanotubes have
become subjects of major interest due to their significant advantages including facile synthesis,
self-organization, control in diameter size, and high efficiency. A number of protocols have been
reported for the preparation of the noncovalently self-assembled nanotubes using different
structures including hollow bundles of rod-like units, helical structures, and stacked rings. It is
generally known that the simplest peptide block for the self-assembly is diphenylalanine peptide
(L-Phe-L-Phe, FF),8 which forms a tubular structure with a long persistence length (~ 100 µm).
The self-assembly is mediated through hydrogen bonding as well as π–π stacking of aromatic
residues. Other tubular structures include cyclic peptide and peptide amphiphile nanotubes.
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2.1.1. Cyclic Peptide Nanotubes
The self-assembled cyclic peptide nanotubes formed by stacking of peptides and
stabilization by hydrogen bonds have attracted major interest because of the ease to change their
structural and functional properties. For this kind of self-assembly, peptides can adopt particular
orientation, where amino acid side chains are directed toward outward whiled the carbonyl and the
amino groups of the peptide backbone are directed perpendicular to the ring and participate in
intermolecular hydrogen bonding.
The pioneer work on cyclic peptide nanotubular structures was carried out by Ghadiri and
co-workers.9a They demonstrated a new class of organic nanotubes based on rationally designed
of heterochiral cyclic peptides. These peptides formed extended β-sheet-like structures, and
stacked on top of each other to form hollow and extended cylinders.9 The peptide nanotubes were
formed using the sequence: cyclo[(D-Ala-Glu-D-Ala-Gln)2]. The investigators used alternating Dand L-amino acids in making the cyclic heterochiral octapeptide that generated a planar ring and
self-assembled through hydrogen bonding to form nanotube structures with a specific diameter.
The self-assembly was triggered in acidic environment and generated nanotube structures through
hydrogen bond interactions of ring-shaped peptides subunits. They hypothesized that cyclic
peptide having an even number of alternating D-and L-amino acids could adopt a low-energy ring
shaped flat conformation. All backbone peptide amide groups became orientated perpendicular to
the plane of the structure and participate in backbone-backbone intermolecular hydrogen bonding
to generate an adjacent antiparallel β-sheet structure (Figure 1). Thus, controlled acidification of
alkaline peptide solution triggered the spontaneous self-assembly of peptide subunits into rodshaped crystals, which was an organized collection of hundreds of tightly packed nanotubes.
Intersubunit hydrogen bonding provided the main driving force in the assembly process. In
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contrast, ring stacking is not favorable at alkaline pH, due to the repulsive intermolecular
interactions between the negatively charged carboxylate side chains of glutamate. The internal
diameter of the nanotubes ranged between 7-8 Å and was controlled by changing the number of
amino acids in the peptide sequence.10

Figure 1. Cyclic peptide structures with alternating D- and L-amino acids adopted flat ring-shaped
conformations and assembled into ordered parallel arrays of solid-state nanotubes. The illustration
emphasizes the antiparallel ring stacking and the presence of extensive hydrogen-bonding
interactions between subunits (for clarity most side chains are omitted). Reprinted with permission
from ref. 10. Copyright 2013 American Chemical Society.

Various applications of these peptide nanotubes have been explored in diverse fields. The
structural features of these cyclic peptides were very unique. When they were placed in such a
7

condition that formed hydrogen bonding, for example, adsorption onto lipid membranes, they
stacked to form hollow, β-sheet like tubular structures. The authors suggested that rationally
designed cyclic D,L-α-peptides could potentially self-assemble in bacterial membranes and exhibit
antibacterial activity by increasing the membrane permeability.11 These cyclic peptides decorated
with suitable hydrophobic surface residues formed transmembrane channel structures by
spontaneous self-assembly on inclusion of an ample concentration of the peptide monomer in lipid
bilayers. They further suggested that not only the hydrophobic nature of the channel-forming
peptide was a major factor, but also the peptide played a part in extended hydrogen-bonded
stacking interactions to construct long channel structures to wrap the lipid bilayer. Ghadiri et al
proposed that the transmembrane channel structures with larger pore diameters could have
potential application in molecular transport across lipid bilayers and can be used as a delivery tool
into living cells in antisense and gene therapy applications.9b
Another cyclic peptide that was reported to self-assemble into tubular structures was the
Lanreotide octapeptide, which was synthesized as a growth hormone inhibitor.12 Lanreotide was
shown to self-assemble into nanotubes of viral capsid-like dimension. The nanotube walls were
composed of helical filaments that were formed by self-assembly of peptide dimer building blocks
to antiparallel β-sheets through an alternating pattern of the aromatic amino acid and aliphatic
residues.

2.1.2. Peptide Amphiphile (PA) Nanotubes
Some nanotubular structures were also formed by self-assembly of peptide amphiphiles
(PAs).13 PAs represent a simple category of the designed self-assembling peptides bearing the lipid
or surfactant characteristics. They possess a hydrophobic tail and a hydrophilic head. The tails of
8

PAs are normally composed of nonpolar amino acid residues (G, A, V, I, L, P and F). The tails
also can be made of hydrocarbon chains or combination of the hydrocarbon chain and nonpolar
amino acids. Positively charged amino acids (H, K, and R) and/or negatively charged residues (D
and E) have been found as appropriate to be used in heads. Glycine rich amphiphilic peptide GnD2–
OH (where n= 4, 6, 8, 10) generated nanotubular structures with two dimensions, one with 40-80
nm and another in the order of 100-200 nm.14 Molecular modeling studies revealed that peptides
formed bilayer structures to confiscate the glycine chains from the aqueous system. Nevertheless,
unlike lipids, peptides formed hydrogen bonds with one another on the backbone. The glycines
were filled inside of the bilayer away from water and the aspartic acids were exposed to water,
similar to other surfactants (Figure 2).

Figure 2. Molecular modeling of cut-away structures formed from the peptides with negatively
charged heads and glycine tail. Left picture shows peptide nanotube with an area sliced away.
Right picture exhibits a peptide nanovesicle. Color code: red, negatively charged aspartic acid
heads; green, nonpolar glycine tail. The modeled dimension is 50-100 nm in diameter. Reprinted
with permission from ref. 14. Copyright 2013 American Chemical Society.

9

Interestingly, peptides containing alanine and valine tails have been found to form more
stable structures than those of glycine, isoleucine, and leucine. Peptides containing valine, AcV6D-OH formed nanotube as well as nanovesicles. Tubular structures were found in selfassembly of other PAs, such as trifluoroacetate salt of A6K and I3K (Ac-I3K-NH2).15a The diameter
of nanotube formed by A6K peptide was found to be 25-30 nm, whereas the diameter of nanotubes
formed by shorter peptide, I3K was about 10 nm and lengths over 5 µm. The formation of
nanostructures from the short peptide clearly indicates that the balances between the peptide
sequence and the size of hydrophobic residues controls the amphiphilicity of a peptide. Then, FTIR
and solid sate NMR (SSNMR) spectroscopy was used to elucidate the molecular architecture of
the peptide nanotube formed by A6K.15b Qualitative information from FTIR indicated that
antiparallel β-strands aligned perpendicular to the nanotube axis. SSNMR technique revealed the
tilt angle of the peptide hydrogen bonding axis within the nanotube framework. This class of
peptide surfactant exhibited properties similar to those of common surfactants, such as n-dodecylβ-D-maltoside (DM) and octyl-D-glucoside (OG). The potential applications of these peptides
were investigated by using A6D as a model peptide surfactant in the stabilization of membrane
protein, such as G protein-coupled receptor bovine rhodopsin.15c A6D not only showed efficiency
in stabilizing the membrane protein in the presence of lipid and other common surfactants, but also
it can be used as stabilizer alone under thermal denaturation conditions without any common
surfactants.
Sometimes molecular geometry also affects the formation of nanostructures. For example,
cone-shaped PA, Ac-GAVILRR-NH2, which has a hydrophobic tail with increasing
hydrophobicity and a large cationic head group composed of two arginine residues led to the
formation of the simultaneous shapes of nanosphere and nano-doughnut structures (Figure 3).16
10

The outer and inner diameters of the doughnut-shaped structures were around 110 nm and 25 nm,
respectively. Self-assembly pathway leading to the pattern of doughnut-shaped nanostructures was
probably through fusion or elongation of short spherical micelles that merged side by side to form
that nanostructures.17

Figure 3. Proposed plausible self-assembly process of the nanodoghnut structure. (A) Randomly
oriented and distributed peptides at low concentration; (B) Micelle formation above the critical
aggregation concentration (CAC); (C) Fusion or elongation of the micelles for the formation of a
nanopipe; (D) Bending of the nanopipe for the formation of a nanodoughnut structure. Reprinted
with permission from ref. 16. Copyright 2013 American Chemical Society.

Cone-shaped

peptide

amphiphiles

Ac-A2V2L3WE2/7–OH

that

were

produced

recombinantly from the bacterial culture,18 formed nano-vesicles with radius size around 60 nm.
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Self-assembly of this peptide started at pH 5.0. This pH triggered self-assembly could be
particularly useful in drug delivery applications.
Effect of molecular structure was found in the self-assembly of the series of PAs, such as
AmK (where m = 3, 6 and 9). These peptides showed different shapes and size with increasing
hydrophobic tail length. A3K peptide aggregated at higher concentration compared to A6K and
A9K, probably due to its weak hydrophobicity. A3K formed unstable peptide sheet stacks. In
contrast, A6K formed long nanotubes while A9K self-assembled into short nanorods (Figure
4).19,20a

Figure 4. Schematic illustration of peptide surfactant self-assembly. (a) A3K had the shortest chain
and had no apparent critical aggregation concentration (CAC) detected, giving rise to the lowest
effective ae (equilibrium area occupied by each surfactant at the curved interface in the aggregate)
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and the highest packing parameter; consequently, stacked A3K bilayers were formed. (b) With
increasing hydrophobic tail length and decreasing CAC of A6K, the electrostatic repulsion between
the head groups increased. This, together with the packing and entropic effect, led to the lowering
of the packing parameter and the formation of nanofibers. (c) A9K had the lowest CAC, the highest
electrostatic repulsion between head groups, and the largest entropic effect arising from the longest
tail, resulting in the lowest p and the formation of nanorods. In each case, lysine (K) groups
remained at the outer surface of the nanostructures formed. Reprinted with permission from ref.
19. Copyright 2013 American Chemical Society.

The nanofibers formed by A6K had the uniform diameter of 8 nm with quite flexible in
nature. Transmission Electron Microscopy (TEM) image of A9K showed the formation of thin and
short nanorods with a diameter of 3 nm and length of 100 nm. The trend is consistent with packing
theory extensively used for common surfactants.
A dialkyl tail containing PA was developed by Matthew et al.20b to design micelles as
antigen delivery vehicles in vivo. Two palmityl chains (C16) was conjugated to a peptide containing
a cytotoxic T-cell epitope derived from ovalbumin. The peptide sequence was termed as OVA
(EQLESIINFEKLTWE). DiC16-OVA amphiphiles self-assembled into cylindrical micelles.

2.2.

Nanofibers
Nanofibers are defined as fibers with a diameter size of less than 100 nanometer. Basically,

the difference between nanofibers and nanotubes is that nanotubes are hollow structures. Herein,
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we discuss the nanofibers formed by PAs and peptides with alternating hydrophobic and
hydrophilic amino acids

2.2.1. PAs as Nanofibers
This category of structures is mostly generated by PAs, which consist of hydrophobic alkyl
tails and hydrophobic heads, similar to lipids. Phospholipid membrane in the biological systems
also composes of a hydrophilic head and a hydrophobic tail. PAs self-assemble into ordered
structures in water through hydrophobic interactions. PAs have the structural features of both
amphiphilic surfactants and functions of bioactive peptides. These molecules generally assemble
in water into nanofibers at specific solution conditions (temperature, pH, and ionic strength).
Furthermore, it has been demonstrated that stable nanofibers can be formed by mixing two
oppositely charged PA molecules to support favorable ionic interactions.21
A broad class of amphiphilic molecules has been used to create organized biomaterials by
Stupp and co-workers. For example, an artificial 3D scaffold consisting of nanofiber networks was
formed by the aggregation of the amphiphilic molecule IKVAV. This process was triggered by the
addition of neural progenitor cell suspensions to the aqueous solution.22 The investigators used the
3D network of nanofiber scaffold to encapsulate cells in vitro which promoted very rapid
differentiation of cells into neurons.
To investigate the nature of the interiors of self-assembled cylindrical aggregates, Stupp
and coworkers explored fluorescence techniques using fluorophores, such as tryptophan or pyrene,
in the peptide backbone.23 PAs bearing fluorophores (tryptophan or pyrene) when self-assembled
at low pH and exhibited differing degrees of exposure to the solvent and accessibility to the
14

quencher. Interior of tryptophan bearing amphiphiles nanostructures remained well solvated
irrespective of the positions of fluorophore, suggesting easy access of hydrophilic molecules inside
the aggregates. Stern-Volmer quenching analysis, a method for quantifying the degree of solvent
exposure of a protein, indicated different degrees of quencher (pyrene) infiltration into the
nanostructures.
Stupp and his group also designed a series of PAs to make one dimensional cylindrical
nanostructures. PAs containing hydrophobic alkyl chains self-assemble into nanofiber structures
because of hydrophobic collapse and β-sheet formation.24 Upon pH changes, these PAs formed
aqueous gels. The stability of these materials can be increased by reversible polymerization. Their
one dimensional fiber structures were restricted when theses PAs were mixed with dumbbellshaped template containing hydrophobic oligo (p-phenylene ethynylene) core.25 Atomic Force
Microscope (AFM) and TEM data revealed a significant change in the PA supramolecular
aggregation from nanofibers to small monodisperse nanostructures upon the addition of the
dumbbell shape scaffold.25
Self-assembly of PAs into nanofibers was also triggered by light as shown by Stupp and
his group.27a A photoacid generator (PAG) was introduced to lower the pH upon exposure to light
to promote the self-assembly of the pH-responsive PAs inside liposomes. Encapsulation of PAs
within the aqueous interior of liposomes was carried out by using a PA solution to hydrate a
phospholipid film. The light-triggered PA self-assembly and encapsulation were confirmed by
confocal fluorescent microscopy, Scanning Electron Microscopy (SEM), Fourier Transform
Infrared Spectroscopy (FTIR), and circular dichroism (CD). The investigators proposed that
packed nanofibers within the interior of liposomes could have potential application in targeting
specific tissues or tumors.
15

Self-assembly of amphiphilic oligopeptide consisting of arginine headgroups into fibril
structures was investigated by Hamley et al.27b Alanine-rich peptide A12R2 containing twelve
alanine residues and two arginine residues was synthesized via N-carboxyanhydride (NCA)polymerization method. Self-assembly was driven by the electrostatic repulsion between the
arginine headgroups, leading to the formation of twisted fibril and stacking of alanine residues.

Castelletto et al explored the possibility of self-assembly of a bioactive dipeptide LCarnosine (βAH, where A = alanine, H = histidine) by incorporating a bulky aromatic
substituent.27c Fmoc [(N-(fluorenyl-9-methoxycarbonyl)], commonly used as protecting agent in
solid-phase peptide synthesis has been used as structure-directing agent to induce fibrillization of
carnosine. Fibrillization of carnosine occurred via π-π stacking interaction. They also
demonstrated that this Fmoc-peptide retained the chelating property with Zn2+ ions even after
fibrillization. They further extended their work by incorporating a lipid chain with L-carnosine to
investigate the self-assembly of βAH.
C16 palmitoyl lipid chain has been used as structure-directing agent to induce the
fibrillization of βAH.27d PA hexadecyl-(β-alanine-histidine) (C16-βAH) self-assembled into
nanotape structures due to the hydrophobicity and excluded volume constraints imposed by the
lipid tail. The investigators further demonstrated that the addition of C16-βAH to DPPC
(dipalmitoyl phosphatidylcholine) multilamellar vesicles led to the formation of well-defined
unilamellar vesicles.
The self-assembly behavior of commercially available PA, matrixyl consists of palmitoyl
(C16) hydrophobic chain and peptide KTTKS was investigated by Valeria et al.27e C16-KTTKS was
incorporated into antiwrinkle skin care creams with the trade name of Matrixyl. This compound
16

self-assembled in a relatively dilute solution. The acetate salt of this PA formed a giant fibrillar
structures with several micrometer length. Investigation at the nanoscale revealed extended tape
structures with a persistent length extending to ten of microns or more. Small angle X-ray
scattering (SAXS) indicated a bilayer structures within the tape. In contrast, the TFA salt of peptide
amphiphile C16-KTTKS exhibited temperature-dependent self-assembly behaviour.

27f

At higher

temperature, it formed micelles instead of nanotape structures. At low temperature, β-sheet
nanotape was stabilized by hydrogen bonding whereas hydrogen bonding was disrupted at higher
temperature. Self-assembly of C16-KTTKS was fine-tuned by adjusting the pH of the solution.27g
As the pH decreased from 7 to 4, a transition in morphology occurred from tape to twisted fibrils.
Again it formed tape like structures at lower pH (pH 3). In contrast, spherical micelles were
observed at pH 2. Nanotape structures were also found when C16-KTTKS was mixed with C16ETTES.27h Electrostatic interactions between anionic residue E (glutamic acid) and cationic
residue K (lysine) led to the formation of fibrillar self-assembled structures.
Self-assembly of tryptophan containing PA C16-W3K exhibited transition in morphology
from spherical micelles to worm like micelles.27i Initially, it showed discrete spherical micelles
structures of diameter about 10 nm. In contrast, after 13 days it exhibited long nanofibrillar
structures with outer diameter of approximately 10 nm. It was hypothesized that the transition was
probably due to the peptide configurational transition. The CD results indicated that the secondary
structure of the molecule changed from mixture of α-helix and random coil to β-sheet with time
without any external stimuli.
PAs also self-assembled into nanostructures in presence of macromolecules. The cationic
Lys-PA self-assembled (C12-VVAGK-Am) into nanofiber in presence of Bcl-2 antisense
oligonucleotide (ODN) through electrostatic interaction.27j This conjugate was investigated for the
17

slow release of ODN from the nanofiber network. Moreover, it delivered the antisense
oligonucleotide efficiently inside the cells in controlled way, which resulted the down regulation
of Bcl-2 mRNA levels, indicating the potential use of PA in gene targeted therapy.
Self-assembly of bacteria-derived lipopeptides was investigated by Hamley et al.27k The
lipopeptides surfactin, plipastatin, and mycosubtilin consisting of cyclic peptide head groups and
different alkyl chains were obtained from Bacillus subtilis. Surfactin and plipastatin selfassembled into spherical micelles whereas mycosubtilin formed extended nanotape structures. The
distinct mode of self-assembly of mycosubtilin compared to the other two peptides was attributed
due to the differences in the surfactant packing parameters.
Polymer containing PAs have been designed and the bioactivity of the self-assembled
structures has been investigated by Valeria et al.27l Peptide DGRFFF containing the RGD cell
adhesion motif was conjugated with poly(ethylene glycol) (PEG) chain of molar mass 3000 kg
mol-1. At high concentration the polymer-peptide conjugate formed nanofibril structures despite
the presence of crystallization of PEG, which occurs during drying process, indicating the strong
tendency of aggregation of the conjugate. Cell proliferation was observed in presence of the
conjugate at optimum concentration.
Incorporation of titanium-based biomaterials in the existing tissues is one of the key
problems in the area of orthopaedic and dental implants. To address this biocompatibility issue,
Hakan et al demonstrated the biofunctionalization of titanium by immobilizing a bone ECMmimetic self-assembled peptide nanofiber on the metal surface.27m To accomplish this, two PAs
were designed. In one sequence, PA molecule (Lauryl-VVAGE) was covalently conjugated to
Dopa (3,4-dihydroxy-L-phenylalanine) which showed strong binding with hydrophilic surface.
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Another PA molecule (Lauryl-VVAG) was conjugated to a heparin binding adhesion peptide
sequence, KRSR. These conjugated molecules Lauryl-VVAGE-Dopa-Am (Dopa-PA) and LaurylKRSR-Am (KRSR-PA) exhibited self-assembled nanofiber structures driven by electrostatic
interaction at the physiological pH via β-sheet formation.
A PA molecule incorporating photocleavable groups between hydrophobic and peptide
domains were designed by Muraoka et al.28 This PA molecule consisted of a 2-nitrobenzyl group,
a palmitoyl tail, and an oligopeptide segment GV3A3E3. The 2-nitrobenzyl group was covalently
linked to the N-terminal amide of the glycine residue and was cleaved by irradiation at 350 nm
(Figure 5). This PA molecule containing the photocleavable group self-assembled into quadruple
helical fibers, which was converted to a nonhelical fibril upon irradiation.

Figure 5. Cleavage of 3-nitrobenzyl group from a PA molecule consisting of a 2-nitrobenzyl
group, a palmitoyl tail, and an oligopeptide segment GV3A3E3. Reprinted with permission from
ref. 28. Copyright 2013 American Chemical Society.
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2.2.2. β-Sheet Peptides with Alternating Hydrophobic and Hydrophilic Amino Acids as
Nanofibers
The β-sheet structure, along with the α-helix, is one of the major secondary structural
elements in proteins. The polypeptide chains remain as extended β-sheet structure. The nearby βstrands can lie in either a parallel or an antiparallel fashion. In both fashions, the orientation of the
β-strands become such a way that alternate amino acid side chains remain towards the opposite
sides of the sheet. Sometimes, the electrostatic and hydrophobic forces among the amino acid side
chains stabilize the sheets.
Peptides containing alternating hydrophilic and hydrophobic amino acid residues are
known to have a strong tendency to generate β-sheet structures.26,29 Alkylated peptide amphiphiles
consisting of hydrophobic and negatively charged residues (V and E) and an alkyl chain with 16
carbons (C16H31OVEVE) self-assembled into flat 1D giant nanobelt structures.26 The structural
template of VEVE flips the hydrophilic and hydrophobic side chains to the opposite sides of the
peptide amide backbone when adopting an extended β-strand conformation. It was hypothesized
that hydrophobic valine residue had a tendency to form a dimer to avoid exposure to water.
Tapping-mode AFM imaging revealed the flat, belt like morphology of the nanostructures formed
in aqueous solution over the course of 2 weeks. The investigators assumed that the alternating
sequence of amino acids led to more effective chain packing within the peptide region and
formation of the nanobelt morphology (Figure 6).
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Figure 6. Nanobelts assembled from a PA containing four amino acids and an alkyl tail. (a)
Chemical structure of the PA. (b-d) AFM images of peptide nanobelts at different scanning sizes.
The assembled nanobelts are the dominant structures in the assembly system (almost artifact free).
Reprinted with permission from ref. 26. Copyright 2013 American Chemical Society.

Interestingly, replacing the VEVE peptide segment with a structural motif of VVEE having
different sequence of amino acids residues led to the formation of cylindrical nanofibers under
similar conditions (Figure 7). On the other hand, when alternating sequence of VEVE was
replaced with VVEE, the cylindrical curvature was regained back as shown in Figure 7.
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Figure 7. Cryo-TEM image of 0.1 wt % C16H31OVVEE aqueous solution clearly demonstrates
cylindrical nanofibers. Reprinted with permission from ref. 26. Copyright 2013 American
Chemical Society.

Short peptide KFE8 (FKFEFKFE) having an alternating pattern of hydrophobic and
hydrophilic amino acids was shown to form self-assembled nanofiber structures. Mechanistic
studies showed that it formed helical ribbon initially, which transformed into fibrillar structures.30
Molecular dynamics simulation revealed the possibility of double helical β-sheet formation. Later,
Matsuura et al. extended the work by designing three way junctions, C3-symmetric conjugate
trigonal (FKFEFKFE)2 consisting of three β-sheet-forming peptide FKFEFKFE (Figure 8).31 This
peptide conjugate self-assembled into viral-sized peptide nanospheres. The above mentioned
conjugate was soluble in acidic water but was hardly soluble in neutral and alkaline water. The
CD spectrum of this peptide in aqueous HCl showed negative peak at 219 nm, suggesting the
formation of β-sheet structures. Another negative peak at 200 nm was probably attributed to an
induced CD for the benzene ring or amide bonds of the core molecule, since a CD peak was not
observed for the component peptide FKFEFKFE alone. On the contrast, FT-IR showed bands
22

which were characteristic of antiparallel β-sheet structures. These combined results clearly indicate
that this trigonal peptide forms hydrogen-bond-mediated intermolecular assemblies as it is not
possible for a single trigonal (FKFE)2 molecule to form β-sheets in an antiparallel manner. The
investigators proposed that this strategy could be widely applied to the design of spherical bionanoassemblies.
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Figure 8. Synthesis of a C3-symmetric β-sheet peptide conjugate and schematic illustration of the
self-assembly. Reprinted with permission from ref. 31. Copyright 2013 American Chemical
Society.

Stimulus-responsive peptide self-assembly provides a powerful approach to control the
self-assembly as a function of environment. Various stimuli-responsive systems including pH,
ionic strength, temperature, light, and enzymes have been designed for peptide self-assembly.
Recently, additional microenvironment-sensitive triggers for self-assembly was developed by
Bowerman et al.32a The investigators explored the concept of reductive trigger for peptide selfassembly. The amphipathic Ac-(FKFE)2-NH2 sequence, known to form self-assembled fibril
nanostructures, when flanked with a cysteine (Cys) residue, Ac-C(FKFE)2CG-NH2, it formed
macrocyclic structure via disulfide bonding and prevented the β-sheet formation that was needed
for self-assembly. On reduction of this disulfide bond, the peptide transformed into the stable βsheet conformation which resulted into self-assembled fibrillar structures. At sufficient peptide
concentration, it formed rigid hydrogels with viscoelastic properties (Figure 9).
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Figure 9. Cyclic to linear peptide conformational switch using a reductive trigger. Reprinted with
permission from ref. 32a. Copyright 2013 American Chemical Society.

2.3. Other Peptides with β-Sheet Structures
Traditionally, peptides are made chemically or using genetic engineering for studying the
self-assembly process. These methods are expensive and time consuming. Moreover, it is really
challenging to design the proper sequence to achieve the desired morphology. Jinming et al.,
demonstrated one simple method to obtain an octapeptide sequence, GAGAGAGY, from the
natural resource, Bombyx mori silk fibroin.32b Based on this sequence, a PA, C12-GAGAGAGY
was constructed and its self-assembly nature was investigated. It formed cylindrical nanofibers at
pH 9 and twisted nanofibers at pH 4, indicating the involvement of electrostatic interactions in the
self-assembly process.
The incorporation of self-organizing peptides into synthetic polymeric materials has been
investigated by various research groups. This kind of peptide-polymer bioconjugate is well
documented in the literature.32c,32d It was found that alanylglycine (AG) repeating units formed
extended β-strands in a variety of AG-rich polypeptides. On the basis of this idea, polypeptides
containing repetitive sequence [(AG)xEG]n (x = 3-6) was made, which formed extended-plate-like
assembled structures. When [(AG)3EG]n β-sheet polypeptides were conjugated to polyethylene
glycol (PEG) end blocks, it prevented the macroscopic aggregation of the β-sheet blocks into
needle-shaped lamellar crystals.33a However, it led to the formation of well-defined fibrils.
Microscopy data suggested that fibril formation occurred in the β-sheet stacking direction which
resulted in an assembly in which the hydrophobic β-sheet surfaces were screened from the polar
solvent, whereas the PEG chains were in contact with the environment.
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peptide

self-

assembly/disassembly process. To address this issue, Joris et al. demonstrated the disassembly of
the peptide sequence Ac-KTVIIE-NH2 by manipulating hydrophobic-hydrophilic balance.33b To
investigate the effect of hydrophilic group in the self-assembly process, a PEG group was
introduced on the C-terminus of the fibril forming peptide. The resulted PEG-peptide conjugate
did not exhibit any assembled structure, presumably due to the high hydrophilicity. However, upon
introducing the hydrophobic tail via photocleavable linker on the N-terminus fibril structure
returned via β-sheet formation. When the hydrophobic tail cleaved on UV radiation, β-sheet
structure was disrupted and consequently the fibrillar structure was damaged.
Peptides adopting β-sheet secondary structures have been suggested to be useful for various
applications, such as nanowires, fibers for biomedical purposes, scaffolds in tissue engineering, or
to direct transport.34 However, only short fibers up to 4 µm in length are accessible. To achieve
extended and strong nanofibers, which is stable enough to mechanical stress and eventually more
useful in materials science, peptides with a higher tendency to form stable aggregates, are needed.
However, the solid-phase supported synthesis (SPPS), purification, and analysis of these peptides
is actually difficult. To address this issue, Hentschel et al studied peptide guided assembly of
polyethylene oxide (PEO)-peptide conjugate (Figure 10).35 The peptide containing valine and
threonine, [(Thr-Val)5], which has a high β-sheet propensity and aggregation tendency, was
conjugated to PEO and an acid labile linker was used to liberate PEO-peptide conjugate from the
solid support. This conjugate organized into a long, nonbranched fibers of width about 2 µm and
lengths up to several millimeters.
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Figure 10. Spontaneously formed aggregates by peptide guided assembly of PEO-peptide
conjugate. Light microscopy (left) and SEM micrograph (right). Reprinted with permission from
ref. 35. Copyright 2013 American Chemical Society.

Most of the artificial β-sheet peptides are designed in such a way that the polar and
hydrophobic amino acids are placed alternatively. This kind of arrangement promotes the
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hydrogen bonding between amide hydrogen and carbonyl oxygen. When one side of the β-sheet
contains hydrophobic amino acid residues, removal of hydrophobic residues from aqueous contact
forces two β-tapes to associate into bilayered β-sheet nanoribbon (β-ribbon) structure. Recently, it
was observed that coupling of a hydrophilic and bioactive peptide to a β-sheet forming peptide
would enable the formation of 1D nanostructure decorated with bioactive peptides. Based on this
idea, a supramolecular building block, Tβp was made which consisted of a cell penetrating peptide
(CPP) Tat and a β-sheet forming peptide.36,37
It was found that the block peptide formed a β-ribbon structure in which β-sheet interaction
was the main driving force for the self-assembly. The Tβp β-ribbons (Figure 11) were able to
encapsulate hydrophobic guest molecules, such as pyrene or Nile red, in the hydrophobic space
between two β-tapes. Moreover, it was observed that cell penetration efficiency of the Tβp βribbon was much higher than that of Tat-CPP only, suggesting that the multivalent coating of CPPs
is advantageous in increasing cellular uptake efficiency.
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Figure 11. Structure and sequence of TβP peptides. Reprinted with permission from ref. 36.
Copyright 2013 Wiley Publishing Group.

2.4.

Vesicle/Spherical Structures
Amphiphilic oligopeptides consisting of various ratio of hydrophilic to hydrophobic block

length are able to self-assemble into vesicular structures in aqueous solution at neutral pH. It has
been shown by Van-Hell et al. that hydrophilic compounds could be encapsulated within the
peptide vesicles.18 These peptides were recombinantly produced in bacteria as an alternative to
solid-phase synthesis. Other types of peptides that could be self-assembled to vesicles were
copolypeptides, proline-rich peptides, and cyclic peptides.

2.4.1. Copolypeptides
Deming and coworkers reported the self-assembly behavior and application of poly(Llysine)-b-poly (L-leucine), poly (L-glutamic acid)-b-poly (L-leucine), and poly(L-arginine)-bpoly (L-leucine) diblock polypeptides, where ‘b’ denotes block.38-40 Charged amphiphilic block
copolypeptides formed stable vesicles and micelles in aqueous solution. Aqueous self-assembly of
opposite charged poly(L-lysine)-b-poly(L-leucine) and poly(glutamic acid)-b-poly(L-leucine)
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block copolypeptides led to the formation of unilamellar vesicles.38 The driving force for the
aggregation of the diblock polypeptides was the α-helical hydrophobic rod formation of the
poly(L-leucine) block. The diblock polypeptides formed vesicular structures at low hydrophobic
residue contents (10-40 mol%). Amphiphilic diblock copolymers formed small spherical or
cylindrical micelles in this composition range, and vesicle structures were found at higher
hydrophobic contents (approximately 30‒60 mol%). This divergence was attributed to the rigidity
of the chain conformation and strong interactions. The polyarginine coated vesicles showed
potential as intracellular delivery following entrapment of hydrophilic molecules. The guanidine
groups of arginines as crucial residues of cell penetrating peptides were responsible for the
effective delivery of the vesicles and cargos.
Holowka et al. used Texas Red labeled dextran, a water soluble cargo, to check the integrity
of the vesicle membrane of poly(L-lysine)-b-poly(L-leucine). The cargo was encapsulated during
vesicle assembly and after dialysis.39 Formed vesicles showed to contain encapsulated dextran.
Though positively charged polypeptides were relatively unstable, whereas negatively charged
polypeptides vesicles were quite stable.
Rodriguez-Hernandez et al. reported pH sensitive vesicles formation for zwitterionic
diblock copolypeptides containing poly-L-glutamic acid-b-poly-L-lysine (PGA-b-PLys).41
Copolypeptides changed from a random coil conformation into a neutral and α-helical structure
(rod) after neutralization of the polypeptide block (Figure 12). At acidic pH, the PGA block was
neutralized, which produced the vesicle in the core while the PLys block formed the shell. In
contrast, under basic conditions, the protonated PLys block was converted into neutral and
insoluble free –NH2 groups that formed the core of the aggregates. It was assumed that the vesicle
formation was attributed to the systematic presence of the polypeptide in a rod like morphology in
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the hydrophobic part of the membrane, making a low interfacial twist and as a result, a hollow
structure was formed.

Figure 12. Schematic representation of the self-assembly into vesicles of the diblock copolymer
PGA15-b-PLys15. Reprinted with permission from ref. 41. Copyright 2013 American Chemical
Society.

Thermally sensitive polypeptides were developed by Dreher et al.42 Temperature triggered
self-assembly of elastin-like polypeptides (ELPs) in a linear AB diblock architecture into a
spherical micelle was carried out through a small increase of temperature to between 37 and 42
C. This temperature range is commonly used for clinical application of hyperthermia. The size of
the micelle was controlled by both the length of the copolymer and hydrophilic-hydrophobic block
ratio.
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2.4.2. Proline-Rich Peptides
The self-assembly of proline-rich peptides was explored by Lee and his group.43,44 Among
naturally occurring amino acids, proline contains a pyrrolidine ring side chain and backbone atoms.
In the cyclic structure of proline, conformational constraints are induced among the atoms in the
pyrrolidine ring, which results the formation of stiff helical rod structures, polyproline type II
(PPII) helix in aqueous solution. On the other hand, biologically active and hydrophilic peptide
coil, Tat cell-penetrating peptide (CPP) is a highly charged peptide and forms a random coil
conformation in aqueous solution. Arginine residues in Tat CPP play the key role in the cell
binding and entry.
Lee and coworkers hypothesized that rigid rod character and the nonpolar nature of the
outer surface of a PPII helix might impart microphase separation characteristics to the rod-coil of
a PPII rod and a hydrophilic coil, leading to the anisotropic orientational ordering of the rod and
self-assembly. Based on this idea, a block polypeptide of polyproline and an arginine oligomer,
P10R3 was designed, and the self-assembly actions were investigated. The secondary structure of
P10R3, consisting of 10 proline and 3 arginine residues showed characteristics of PPII helix.
Microscopy data suggested the formation of vesicles rather than micelles (Figure 13). Another
polypeptide P10Tat also self-assembled into vesicular structures. Both peptides P10R3 and P10Tat
were introduced as potential carriers for delivering hydrophilic drug molecules into cells.
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Figure 13. Structures of peptide rod–coil building blocks and their self-assembly into nanocapsule
structures. Reprinted with permission from ref. 43. Copyright 2013 RSC Publishing Group.

2.4.3. Cyclic Peptides
Linear and cyclic peptides containing same sequence of amino acid residues showed
differential behavior in the self-assembly process. Choi et al. reported that linear peptide
containing tryptophan and arginine residues showed irregular morphologies whereas cyclic
counterpart showed spherical nanostructures.44 Recently, we have performed an extensive
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investigation on the self-assembly process of a number of cyclic peptides including [FR]4, [FK]4,
[WK]5, [CR]4, [AK]4, and [WR]4 containing L-amino acids (Figure 14).45

Figure 14. Chemical structures of synthesized cyclic peptides (F = phenylalanine, R =
arginine, K = lysine, W = tryptophan, C = cysteine, A = alanine). Reprinted with permission from
ref. 45.
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The rationale behind the selection of amino acids in the structure of the peptide was based
on the presence of alternating hydrophobic and positively charged residues or alternating neutral
and positively charged residues in their structures. We hypothesized that the self-assembled
nanostructures in aqueous solution could be formed through intramolecular and/or intermolecular
interactions through an optimal balance of hydrophobicity and charge. Among all the designed
peptides, one of the peptides, namely [WR]4, generated self-assembled nanostructures at room
temperature after a specific incubation time. The presence of the tryptophan’s indole ring of in
[WR]4 was found to play a critical role in self-assembly process due to its high hydrophobicity
through generating potential hydrophobic interactions. Furthermore, the presence of the positively
charged guanidine group in the arginine was found to be involved in hydrogen bonding
interactions. However, other 5 cyclic peptides did not show self-assembled nanostructures possibly
due to inappropriate combination of hydrophobic and positively charged residues. As a result of
the unique behavior of [WR]4, and to investigate the role of the ring size, other derivatives in this
group [WR]3 and [WR]5, were designed and tested to determine the effect of the ring size on the
self-assembly process. TEM was used to investigate the morphologies of [WR]3 and [WR]5. All
compounds in this class showed vesicle-type structures. TEM of [WR]3 showed that this peptide
forms structure within sizes of 100 nm after 14 days of incubation. [WR]4 and [WR]5 were
observed in larger structures (550 and 930 nm, respectively) (Figure 15). The results indicated that
three major elements are involved in the self-assembly process of these cyclic peptides including
hydrophobic force, hydrogen bonding by partial β-structures, and/or the π- π stacking interactions
between tryptophan residues.45
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Figure 15. (a) and (b) FE-SEM image of self-assembled structure of [WR]5 (2 mM) in water after
20 days; (c) TEM images of self-assembled structures of [WR]3 in water after 2 weeks (without
negative staining); (d) TEM images of self-assembled structures of [WR]4 in water after 2 weeks
(without negative staining); (e) TEM images of self-assembled structures of [WR]5 in water after
2 weeks (without negative staining). Reprinted with permission from ref. 45.

We further investigated the new applications of this class of cyclic peptides for generating
cyclic peptide capped gold nanoparticles (CP-AuNPs) as potential drug delivery purposes.46 We
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found out that the combination of tryptophan and positively charged amino acids worked as
reducing/capping agents and led to the formation of in-situ functionalized metal nanoparticles.
Moreover, we noticed that the cyclic peptides containing alternative tryptophan and lysine
(c[WK]5) produce different gold nanoparticles when compared with their linear counterpart
(l(WK)5).47 TEM investigations showed that l(KW)5-AuNPs formed ball-shaped structures with
the diameter size of 900−1000 nm (Figure 16). A large number of l(KW)5-AuNPs were found to
be in spherical morphologies and in the size range of 4−35 nm. The distribution pattern of AuNPs
in of l(KW)5-AuNPs was found to be an organized arrangement.

Figure 16. TEM images of l(KW)5-AuNPs. Reprinted with permission from ref. 47. Copyright
2013 American Chemical Society.

Compared to linear peptide-capped AuNPs, TEM images of c[KW]5-AuNPs showed
sponge-like agglomerates. The spongy agglomerates were composed of peptide and AuNPs with
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an approximate diameter size of 250−450 nm (Figure 17) along with some isolated AuNPs in
spherical and triangular shapes (6−60 nm).

Figure 17. TEM images of c[KW]5-AuNPs. Reprinted with permission from ref. 47. Copyright
2013 American Chemical Society.

These data suggested that the constrained nature of the peptide in c[KW]5-AuNPs caused
different orientation of amino acids in the secondary structure of peptide causing the formation of
different environment surrounding the complex that led to the formation of organized
morphologies by the peptides. This orientation altered the number of available amino acids such
as tryptophan and/or lysine residues in reduction process of the Au3+. However, l(KW)5 more
flexibility in the conformation compared to the corresponding constrained cyclic counterpart
c[KW]5 during the AuNPs formation. Additional positively charged amino groups and negatively
charge carboxylates at N-terminal lysine and C-terminal tryptophan, respectively, could also
participate in self-assembly process through intermolecular interactions of the peptide. Thus, the
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cyclic and linear nature of the peptide and the orientation of amino acids were found to be the main
reason for the different morphology and size of formed P-AuNPs.
Furthermore, the assemblies between a cyclic peptide ([WR]4) as a drug delivery system
and molecular cargos were investigated.48 A negatively charged phosphopeptides (PEpYLGLD)
was selected as a model cargo molecule. TEM investigation of negatively stained [WR]4 alone
showed circular vesicle-like structures with approximate size of 25−60 nm. TEM images of
PEpYLGLD (Figure 18) exhibited mostly amorphous structures with approximate size of 40 nm.
However, when PEpYLGLD was mixed with [WR]4 in solution, PEpYLGLD-loaded [WR]4
formed some larger noncircular morphologies with width and height of 125 and 60 nm,
respectively.
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Figure 18. Negatively stained TEM images of [WR]4 (1 mM), PEpYLGLD (1 mM), and
PEpYLGLD-loaded [WR]4 (1 mM) in water after one day. Reprinted with permission from ref.
48. Copyright 2013 American Chemical Society.

We proposed that the available electrostatic and/or hydrophobic intermolecular
interactions between the positively charged cyclic peptide and negatively charged
phosphopeptides was responsible for the self-assembly process (Figure 19). The structure of [WR]4
was investigated by using TEM microscopy showing modified morphologies upon binding with
PEpYLGLD by generating new nanostructures.

Figure 19. Proposed mechanism of the self-assembly and interactions between PEpYLGLD and
[WR]4. Reprinted with permission from ref. 48. Copyright 2013 American Chemical Society.

In conclusion, our efforts were focused on developing new sequences of amino acids in the
structure of cyclic peptide for biomedical applications.49,50 Our findings showed that the cyclic
nature of the peptide was a critical element in the self-assembly process and their biological
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activity possibly because of the constrained structure and different orientation of amino acids in
their secondary structure.

2.5.

Amyloid Nanofibrils
The self-assembly of peptides and proteins into fibrillar structure formation is very

common phenomena in biological systems. Amyloid fibrils are key examples of protein selfassembly into nano-fibrillar structures.51 The accumulation of amyloid fibrils is a common
characteristic of various diseases including Alzheimer’s disease, type II diabetes, Parkinson’s
diseases, and many others.52 Furthermore, self-assembled nanofibrils generated from natural or
artificial peptides have been suggested for potential application in bionanotechnology. Amyloid
fibrils have β-sheet conformation generated by polypeptides of 30-40 amino acids or longer. It has
been shown that short peptide fragments, for example, tetra- to hexapeptides, form fibrillar
structure with similar biophysical and structural properties of amyloid fibrils.53 Thus, they can be
used as a model system for studying amyloid fibrils formation and biological self-assembly
processes. NFGAIL and FGAIL are very good examples of short peptides, which can selfassemble into fibrillar structure.54
To understand the amyloid fibril formation better, further investigations were conducted to
find the minimum peptide fragment which was responsible for amyloid fibrils formation. It was
found that aromatic residues played critical roles in the process of amyloid formation.
Diphenylalanine (FF) is the core recognition motif of the Alzheimer’s β-amyloid polypeptide. FF
leads the process of self-assembly in the molecule. In fact, dipeptide containing FF underwent selfassembly into nanotubes through a combination of π-π stacking and hydrogen bonding (Figure
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20).55 Larger peptides and conjugated organic molecules that contain this motif inhibited fibrils
formation by Aβ.56,57

Figure 20. The formation of amyloid fibrils. Folded monomer undergoes a conformational
transition into a b-sheet-rich state, usually through a partial unfolded state. Self-assembly of these
intermediates into ladders of b strands results in the formation of ordered filaments that aggregate
into the well-known amyloid fibrils. Reprinted with permission from ref. 55. Copyright 2013
Wiley Publishing Group.

These peptide nanotubes developed from diphenylalanine are significantly rigid and
potentially useful in electrochemical biosensing.58 Gazit et al. and Ulijn et al. found that 9fluorenylmethoxycarbonyl (Fmoc) protected diphenyalanine (Fmoc-FF) self-assembled into
nanofibrils in aqueous solution, which led to a hydrogel formation.55-60 The rheological pattern of
this hydrogel exhibited similarity to solid-like gels materials. This hydrogel was significantly
stable at a wide range of temperatures and pH values including extreme acidic conditions. Recent
molecular modeling studies showed that, peptides in this gel were aligned in an antiparallel β-sheet
fashion and adjacent sheet like interlocked through lateral π-π interactions, which resulted to the
formation of a cylindrical structure.61 Modification of this dipeptide by N-terminal acetylation and
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amidation of the C-terminal carboxyl led to the formation of nanotube structures of similar
properties. These data indicated the key role of aromatic moieties in the generation of peptide
nanotubes.62
Further extension of this study by Gazit et al. showed that diphenylglycine, a similar
analogue of diphenylalanine and the simplest aromatic peptide, formed nanospheres. These
nanostructures were stable under extreme chemical conditions. The introduction of a thiol group
by incorporation of a cysteine residue into FF peptide modified the self-assembly properties of the
resultant building blocks. Cysteine-diphenylalanine tripeptide self-assembled into spherical
vesicles instead of nanotubes.7

2.6.

Rod-Coil/Coiled coil Nanostructures
Rod-coil nanostructures have a chain of rod-like stiffness and flexible coil-like block. Like

other supramolecular building blocks, rod-coil block molecules can be used to construct a variety
of distinct nanostructures of controlled size and shape in some selective solvents. For aqueous selfassembly of this molecule, one part was designed to be hydrophilic, and another part was
hydrophobic. For example, Holowka, et. al. reported the preparation of charged amphiphilic block
copolypeptides that formed vesicles and micelles in water. They were synthesized a class of
poly(L-lysine)-b-poly(l-leucine) block copolypeptides, KxLy, where X = 20‒80 and y = 10-30 amino
acids (Figure 21).63
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Figure 21. Schematic drawing showing proposed self-assembly of K60L20 into vesicles. Reprinted
from ref. 63. Copyright 2013 American Chemical Society.

Lomander et al reported the hierarchical self-assembly of a coiled-coil peptide of 31
residues

containing

charged

and

hydrophobic

residues.64

The

sequence

is

WGCIKQLEDKIEELLSKIY-HLENEIARLKKL. Internal cysteine has been used in the sequence
to generate disulfide covalent bond between two separate peptide coiled-coils. Even though coiled-
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coil peptide contained many charges, the secondary structure of the peptide in all pH ranges
showed a typical α-helix with some variation of helical content. These findings suggested that the
neutralization of the charged residues did not completely disrupt the secondary structure of the
coiled-coil, mainly due to the hydrophobic interactions of two helices.
Coiled-coil peptides were reported to be an effective scaffold for creating new
nanostructures. One such example is demonstrated by Ryadnov et al.65 who designed a nanoreactor
with multiple cavities by using self-assembled supramolecular dendrimers, which were termed as
supradendrimers (SD) in two steps. The first step was the self-assembly of a single peptide
sequence SD-1 (QEIARLEQEIARLEYEIARLE), which was based on a dimeric coiled coil also
known as the leucine zipper. In folding state, SD-1 dimers were rigid rods. However, when selfassembly started and was sustained by the formation of hollow dendrimer cells, the rods extended
into tightly packed noncovalent networks. TEM revealed very dense mesoscopic assemblies of a
hexagonal paracrystalline phase, which proposed with the formation of a hierarchically ordered
architecture of SD-1 supradendrimers.
Second step was to generate cavities in the dendrimer cells. To accomplish this, another
complementary sequence SD-2 [Ac-(K(KIEALKOKIEALKYKIEALK- ɛAhx))3 – am] where
ɛAhx was ɛ-aminohexanoic acid, was assembled with SD-1, resulting a dimer SD-1,2 (Figure 22).
Furthermore, to demonstrate the encapsulation ability of this dimer, a redox reaction was carried
out, where boiling solution of silver nitrate was added into the dimer followed by the addition of
sodium citrate as a reductant. This reaction led to the formation of silver nanoparticles having the
size of the cavities, indicating nanoreactor nature of the dimer.
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Figure 22. Schematic representation of the supradendrimer design. SD-1 (1) and SD-2 (2) peptide
sequences are shown with the one-letter code and are simplified into helical wheels with 3.5
residues per turn. The sequences show heptad repeats characteristic of canonical coiled coils,
commonly labeled a–g. Residues at sites a and d shape helix–helix interfaces. These are
hydrophobic and made up of isoleucine and leucine, respectively, to ensure the formation of
dimers. A) SD-1-type of electrostatic interactions, g–c–e’: e’ and g positions are occupied by
glutamates that form salt bridges with arginine residues at c; g–c interactions are intrahelical,
whereas c–e’ are interhelical and are between two SD-1 copies of different dimers. Dimers
trimerize (I) to give a noncovalent dendrimeric architecture, with a branching cell formed by six
dimers (II). A single cysteine residue in the f position that replaces a glutamine is shown in
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brackets. B) Mixed SD-1/SD-2 (SD-1,2)-type of electrostatic interactions, g–c–e’(1)/b–e, g–e’(2):
intrahelical b–e interactions in 2 inhibit interhelical e–g’ interactions; g–e’ interactions contribute
to the 1–2 interface. Because the width of a superhelix is approximately 2 nm, the diameter of an
extended branching cell (II’) is estimated to not exceed 4–6 nm. To form the supradendrimer II’,
each copy of SD-2 should be arranged with at least nine copies of SD-1 to round the equimolar
SD-1,2 ratio to 10:1. SD-2 wheels are highlighted in black around an ac-KKK-am hub containing
an e-aminohexanoic acid (eAhx) as spacer. The circles of helical wheels are black for arginines,
gray for glutamates, and outlined in gray for lysines. Arrows represent salt bridges. Reprinted with
permission from ref. 65. Copyright 2013 Wiley Publishing Group.
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Table 1. Summary of peptides sequences and their self-assembled nanostructures incorporated in
this review.
Peptide Sequence
L-Phe-L-Phe ( FF)
cyclo[(D-Ala-Glu-D-Ala-Gln)2]
NH2-(D)Naph-Cys-Tyr-(D)Trp-Lys-ValCys-Thr-CONH2
GnD2–OH (where n= 4, 6, 8, 10)
Ac-V6D-OH
I3K (Ac-I3K-NH2)
Ac-GAVILRR-NH2
Ac-A2V2L3WE2/7–OH
A6K
A9K
DiC16-EQLESIINFEKLTWE
IKVAV
A12R2
Fmoc-βAH
C16-βAH
C16-KTTKS
C16-KTTKS and C16-ETTES (mixed)
C16-W3K (1 day)
C16-W3K (13 days)
Polyethylene glycol- DGRFFF
Lauryl-VVAGE-Dopa-Am and LaurylKRSR-Am (KRSR-PA) (Mixture)
Palmitoyl-GV3A3E3
VEVE
VVEE
FKFEFKFE
C3-symmetric peptide conjugate trigonal
(FKFEFKFE)2
Ac-(FKFE)2-NH2
C12-GAGAGAGY
Polyethylene glycol-[(AG)3EG]n
Polyethylene oxide-[(Thr-Val)5]
R-GRKKRRQRRRPPQGSGGFKFEFKFEFKFE
Poly(L-lysine)-b-poly(L-leucine) and
Poly(glutamic acid)-b-poly(L-leucine)
PGA-b-PLys

Nanostructure
Nanotubes
Nanotubes
Nanotubes

Reference
8
9
12

Nanotubes
Nanotubes and nanovesicles
Nanotubes
Nanosphere and nano-doughnut
Nano-vesicles
Nanotubes or nanofibrils
Nanorods
cylindrical micelles
nanofiber
twisted fibril
Nanofibril
Nanotape
Fibrillar
Nanotape
Spherical micelles
Worm-like micelles
Nanofibril
Nanofiber

14
15a
15a
16
18
19
20a
20b
22
27b
27c
27d
27e
27h
27i
27i
27l
27m

Fibril
Nanobelt
Cylindrical nanofibers
Nanofiber
Nanospheres

28
26,29
26
30
31

Amyloid fibril
Nanofiber
Fibril
Fibers
Nanoribbon

32a
32b
33a
35
36

Vesicles

38

Vesicles
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48

P10R3, P10Tat
[WR]n (n=3-5)
l(KW)5-AuNPs
c[KW]5-AuNPs
PEpYLGLD-loaded [WR]4
Fmoc-FF
Diphenylglycine
Cysteine-diphenylalanine tripeptide
Poly(L-lysine)-b-poly(l-leucine)
WGCIKQLEDKIEELLSKIYHLENEIARLKKL
SD-1 (QEIARLEQEIARLEYEIARLE)

Vesicles
Vesicle-like
Ball-shaped structures
Sponge-like agglomerates
Large noncircular morphologies
Nanofibrils
Nanotubes and nanospheres
Spherical vesicles
Vesicles and micelles
Coiled coils
Coiled coils

43,44
45
47
47
48
60
8
7
63
64
65

3. Conclusions and Future outlook
Peptides are highly versatile structural building blocks and can generate supramolecular
architectures, including sheets, spheres, fibres, tapes, and tubes. Self-assembled peptides are able
to form numerous nanostructures through various types of interactions, such as electrostatic,
hydrophobic, and hydrogen bonding. They can take advantage of diversity in the body of amino
acid residues including positive or negative charge along with hydrophobic or hydrophilic
properties. More studies are required in rational peptide design to investigate systematically the
role of hydrophobicity, electrostatics, and size on pattern formation and to examine sequence
effects on morphologies, and elucidate the fundamental physical interactions that drive their selfassembly. These investigations will assist us to determine the guiding principles in terms of roles
of size, charge, and hydrophobicity for self-assembly into specific structures.
Several challenges including size control, undesired aggregation, pH stability and chemical
and enzymatic stability need to overcome in design and functionalizing peptide nanostructures.
The use of peptide nanostructures as drug delivery vehicles, imaging contrast agents and/or
biosensors requires a good stability in the solution in question (e.g., buffer). For instance, Stupp and
his group found that some PAs were unstable upon pH change.24 When a dumbbell-shaped
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hydrophobic core was added into the sequence, it showed enhanced stability.25 However,
extensive studies are required to evaluate the properties of peptide nanostructures upon the pH
change. It was found that tryptophan containing cyclic peptides [WR]n (where n = 3-5) did not
exhibit self-assembled nanostructures immediately, but in a long period of time (approximately 12
days).45 This issue can be addressed by altering the hydrophobic–hydrophilic ratio in the peptide
sequence. The control of the size of peptide nanostructures is very crucial in its applications such
drug delivery systems and biosensors. Nanostructures of equivalent dimension are needed for the
fabrication of biosensing platforms of similar characteristics. It is very challenging to control the size
of the nanostructures during the synthesis due to the self-assembly process. To obtain the
nanostructures of similar dimension, change in fabrication parameters or use of templates can be
beneficial. The size distribution of self-assembled peptides can be controlled with external stimulus,
such as pH, ionic strength, solvent, chemical additives, or temperature. Particle size, charge, and size
distribution can be intelligently engineered to affect the stability of self-assembled structure and
encapsulation properties. Because of the presence of hydrophobic groups in some peptides,
aggregation could occur. An optimal balance of hydrophobicity and charge could generate selfassembled nanostructures in aqueous solution by intramolecular and/or intermolecular interactions
minimizing aggregation through hydrophobic groups. In some cases, due to strong interactions some
crude peptides aggregate and thus, difficult to purify. Effective synthetic strategies are needed to
overcome this problem.
Second, self-assembled peptides have been studied in diverse applications ranging from
imaging, biomineralization, tissue engineering, and drug delivery, due to their inherent
biocompatibility and biodegradability. Designing self-assembled peptides has emerged as an
effective tool in applications ranging from energy storage, tissue engineering, drug and gene
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delivery, membrane protein stabilization, due to their inherent biocompatibility and
biodegradability. A deep understanding of self-assembly by amphiphilic peptides through
systematic design and study of unexplored peptide sequences is urgently required to develop the
next generation of self-assembled peptides for various applications, such as encapsulating
hydrophobic compounds. Based on the desired applications, different number and types of amino
acids can be used. Moreover, they can be easily conjugated with antibodies, enzymes, quantum
dots, and metal nanoparticles to enhance their stabilization and biocompatibility. Peptide
nanomaterials as self-assembled structures continue to have potential applications as encapsulation
and/or drug delivery tools. Although further investigations on self-assembled peptide
nanoparticles are required, they have already been used for different applications including drug
delivery, wound healing, tissue engineering, surfactants, and tissue repair. It is envisioned that the
peptide nanostructures may be specifically used in tissue engineering (e.g., wound healing and
nerve regeneration), drug delivery, imaging, and active targeting to disease-relevant cell types for
the efficacious treatment of a variety of ailments, including cancer and neurodegenerative
disorders. Nevertheless, the application of peptide nanostructures in the area of
gene/oligonucleotide delivery has not been explored extensively. The intracellular delivery of such
macromolecules in their active form remains a challenging task. To address this issue, rationally
designed peptide-polymer conjugates with desired properties are needed to explore. Furthermore,
the biocompatibility and immunogenicity of the self-assembled peptide biomaterials is needed to
study completely for possible biomedical applications. The synthesis of a variety of self-assembled
peptides has been previously reported, but a predictive understanding for rational design of peptide
self-assembly is still lacking. Thus, there is an urgent need to study systematically alternative
peptides for establishing the relationship between the morphology of self-assembled peptides with
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their physicochemical properties (e.g., sequence, size, charge, and 3D structure of the monomer).
There is also a need to further study alternative systems for the prediction of structure of selfassembled peptides based on their sequence and other physiochemical properties.
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